The DOI matches its Crossref record.
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Open accessAbstract
The inducible pleiotropic transcription factor NF-kappa B is composed of two subunits, p50 and p65. The p50 subunit is encoded on the N-terminal half of a 105-kDa open reading frame and contains a rel-like domain. To date, no function has been described for the C-terminal portion. We show here that the C-terminal half of p105, when expressed as a separate molecule, binds to p50 and can rapidly disrupt protein-DNA complexes of p50 or native NF-kappa B. Deletion analysis of this precursor-derived inhibitor activity indicated a domain containing ankyrin-like repeats as necessary for inhibition. The protooncogene bcl-3, which contains seven ankyrin repeats, can equally inhibit p50 DNA binding. These observations identify bcl-3 as an inhibitor of NF-kappa B and strongly suggest that the ankyrin repeats in these factors are involved in protein-protein interactions with the rel-like domain of p50. Comparison with other ankyrin repeat-containing proteins suggests that a subclass of these proteins acts as regulators of rel-like transcription factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Crosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
Oxidative stress and gene regulation
Allen, R. G., & Tresini, M. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00242-7 · Cited by 1,302
Beg, A. A., Finco, T. S., Nantermet, P. V., & Baldwin, A. S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3301 · Cited by 1,027
Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., & Dalton, T. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00310-x · Cited by 1,004
IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
Grilli, M., Chiu, J. J.-S., & Lenardo, M. J. (1993) · International Review of Cytology · doi:10.1016/s0074-7696(08)61873-2 · Cited by 936
Molecular Basis of NF-κB Signaling
Napetschnig, J., & Wu, H. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130338 · Cited by 933
The ankyrin repeat as molecular architecture for protein recognition
Mosavi, L. K., Cammett, T. J., Desrosiers, D. C., & Peng, Z. (2004) · Protein Science · doi:10.1110/ps.03554604 · Cited by 907
The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
Beg, A. A., & Baldwin, A. S. (1993) · Genes & Development · doi:10.1101/gad.7.11.2064 · Cited by 794
Beg, A. A., Ruben, S. M., Scheinman, R. I., Haskill, S., Rosen, C. A., & Baldwin, A. S. (1992) · Genes & Development · doi:10.1101/gad.6.10.1899 · Cited by 718
Colbert, H. A., Smith, T. L., & Bargmann, C. I. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08259.1997 · Cited by 630
The Crystal Structure of the IκBα/NF-κB Complex Reveals Mechanisms of NF-κB Inactivation
Huxford, T., Huang, D.-B., Malek, S., & Ghosh, G. (1998) · Cell · doi:10.1016/s0092-8674(00)81699-2 · Cited by 578
Bours, V (1993) · Cell · doi:10.1016/0092-8674(93)90401-b · Cited by 495
Nuclear factor kappa B, a mediator of lipopolysaccharide effects
Müller, J. M., Ziegler-Heitbrock, H. W. L., & Baeuerle, P. A. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80342-6 · Cited by 475
The inducible transcription factor NF-κ B: structure-function relationship of its protein subunits
Grimm, S., & Baeuerle, P. A. (1993) · Biochemical Journal · doi:10.1042/bj2900297 · Cited by 429
NF-κB and Rel Proteins in Innate Immunity
(1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60618-5 · Cited by 428
Franzoso, G., Carlson, L., Poljak, L., Shores, E. W., Epstein, S., Leonardi, A., Grinberg, A., Tran, T., Scharton-Kersten, T., Anver, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.147 · Cited by 425
Autoregulation of I kappa B alpha activity.
Chiao, P. J., Miyamoto, S., & Verma, I. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.28 · Cited by 423
Regulation of serum amyloid A protein expression during the acute-phase response
JENSEN, L. E., & WHITEHEAD, A. S. (1998) · Biochemical Journal · doi:10.1042/bj3340489 · Cited by 411
A Fourth IκB Protein within the NF-κB Signaling Module
Basak, S., Kim, H., Kearns, J. D., Tergaonkar, V., O'Dea, E., Werner, S. L., Benedict, C. A., Ware, C. F., Ghosh, G., Verma, I. M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.033 · Cited by 404
The precursor of NF-κB p50 has IκB-like functions
Rice, N. R., MacKichan, M. L., & Israël, A. (1992) · Cell · doi:10.1016/0092-8674(92)90353-e · Cited by 403
Constitutive NF-kB Activity in Neurons
Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H., & Baeuerle, P. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3981-3992.1994 · Cited by 394
Two Waves of Nuclear Factor κb Recruitment to Target Promoters
Saccani, S., Pantano, S., & Natoli, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.12.1351 · Cited by 389
Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysis
Finco, T. S., & Baldwin, A. S. (1995) · Immunity · doi:10.1016/1074-7613(95)90112-4 · Cited by 385
Activation of NF-kappa B in vivo is regulated by multiple phosphorylations.
Naumann, M., & Scheidereit, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06781.x · Cited by 352
Self-citationZyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton.
Sadler, I., Crawford, A. W., Michelsen, J. W., & Beckerle, M. C. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.6.1573 · Cited by 348
Phosphorylation of IκBα Precedes but Is Not Sufficient for Its Dissociation from NF-κB
DiDonato, J. A., Mercurio, F., & Karin, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1302 · Cited by 337
Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.
Zabel, U., Henkel, T., Silva, M. S., & Baeuerle, P. A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05646.x · Cited by 319
The candidate oncoprotein Bcl-3 is an antagonist of pSO/NF-κB-mediated inhibition
Franzoso, G., Bours, V., Park, S., Tomfta-Yamaguchi, M., Kelly, K., & Siebenlist, U. (1992) · Nature · doi:10.1038/359339a0 · Cited by 319
The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators
Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F. G., Scheidereit, C., & Leutz, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202717 · Cited by 312
Self-citationCotranslational Biogenesis of NF-κB p50 by the 26S Proteasome
Lin, L., DeMartino, G. N., & Greene, W. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81409-9 · Cited by 312
Notch as a Mediator of Cell Fate Determination in Hematopoiesis: Evidence and Speculation
Milner, L. A., & Bigas, A. (1999) · Blood · doi:10.1182/blood.v93.8.2431 · Cited by 293
Yap/Taz regulate alveolar regeneration and resolution of lung inflammation
LaCanna, R., Liccardo, D., Zhang, P., Tragesser, L., Wang, Y., Cao, T., Chapman, H. A., Morrisey, E. E., Shen, H., Koch, W. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125014 · Cited by 288
p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
Mercurio, F., DiDonato, J. A., Rosette, C., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.4.705 · Cited by 282
NF-κB, IκB, and IKK: Integral Components of Immune System Signaling
Mulero, M. C., Huxford, T., & Ghosh, G. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9367-9_10 · Cited by 259
Ganchi, P. A., Sun, S. C., Greene, W. C., & Ballard, D. W. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.12.1339 · Cited by 257
The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation
Wulczyn, F. G., Krappmann, D., & Scheidereit, C. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050078 · Cited by 256
Self-citationHarun-Or-Rashid, M., & Inman, D. M. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1346-7 · Cited by 121
Bergmann, A., Stein, D., Geisler, R., Hagenmaier, S., Schmid, B., Fernandez, N., Schnell, B., & Nüsslein-Volhard, C. (1996) · Mechanisms of Development · doi:10.1016/s0925-4773(96)00607-7 · Cited by 119
Atypical IκB proteins in immune cell differentiation and function
Annemann, M., Plaza-Sirvent, C., Schuster, M., Katsoulis-Dimitriou, K., Kliche, S., Schraven, B., & Schmitz, I. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.01.006 · Cited by 52
Metadata
- Authors
- Hatada, E. N., Nieters, A., Wulczyn, F. G., Naumann, M., Meyer, R., Nucifora, G., McKeithan, T. W., & Scheidereit, C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-03-15
- Volume
- 89
- Issue
- 6
- Pages
- 2489-2493
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2045793427
- Cited by
- 233
- References
- 0
- FWCI
- 16.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.